LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS
Autor(a) principal: | |
---|---|
Data de Publicação: | 1991 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://repositorio.unifesp.br/handle/11600/25174 http://dx.doi.org/10.1097/00005344-199117002-00032 |
Resumo: | The contribution of left ventricular hypertrophy in determining ventricular arrhythmias (VAS) was studied in 81 chronic renal failure patients in chronic hemodialysis using two-dimensional echocardiographic and electrocardiogram Holter monitoring. the prevalence of LVH was 93% (96% in hypertensive and 87% in normotensive patients). the prevalence of VA was 48%. These arrhythmias were associated with increased cardiac mass, lack of potassium supplementation to the hemodialysis bath, and low K+ and PaO2 during dialysis. Severe forms of VA occurred in 19 of 78 patients, and the risk factors for this occurrence were (a) largely increased cardiac mass indices (exceeding in more than 40% the upper limit of normal for each sex) and (b) prolonged periods of time in hemodialysis treatment (34 +/- 5.5 vs. 17 +/- 2.7 months, p < 0.05). Changes in potassium or oxygen content of the blood were not significantly associated with the occurrence of severe forms of VA. |
id |
UFSP_657c8f89477dc3212ac3d798dcc3c0e5 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br:11600/25174 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Saragoca, Manoel A. [UNIFESP]Canziani, M. E. [UNIFESP]Cassiolato, José L.Gil, M. A. [UNIFESP]Andrade, J. L. [UNIFESP]Draibe, S. A. [UNIFESP]Martinez, E. E. [UNIFESP]Universidade Federal de São Paulo (UNIFESP)CENTROCOR2016-01-24T11:40:00Z2016-01-24T11:40:00Z1991-01-01Journal of Cardiovascular Pharmacology. Philadelphia: Lippincott-raven Publ, v. 17, p. S136-S138, 1991.0160-2446http://repositorio.unifesp.br/handle/11600/25174http://dx.doi.org/10.1097/00005344-199117002-0003210.1097/00005344-199117002-00032WOS:A1991FU76000032The contribution of left ventricular hypertrophy in determining ventricular arrhythmias (VAS) was studied in 81 chronic renal failure patients in chronic hemodialysis using two-dimensional echocardiographic and electrocardiogram Holter monitoring. the prevalence of LVH was 93% (96% in hypertensive and 87% in normotensive patients). the prevalence of VA was 48%. These arrhythmias were associated with increased cardiac mass, lack of potassium supplementation to the hemodialysis bath, and low K+ and PaO2 during dialysis. Severe forms of VA occurred in 19 of 78 patients, and the risk factors for this occurrence were (a) largely increased cardiac mass indices (exceeding in more than 40% the upper limit of normal for each sex) and (b) prolonged periods of time in hemodialysis treatment (34 +/- 5.5 vs. 17 +/- 2.7 months, p < 0.05). Changes in potassium or oxygen content of the blood were not significantly associated with the occurrence of severe forms of VA.ESCOLA PAULISTA MED SCH,DIV CARDIOL,BR-04023 São Paulo,BRAZILCENTROCOR,São Paulo,BRAZILESCOLA PAULISTA MED SCH,DIV CARDIOL,BR-04023 São Paulo,BRAZILWeb of ScienceS136-S138engLippincott-raven PublJournal of Cardiovascular PharmacologyLEFT VENTRICULAR HYPERTROPHYCARDIAC HYPERTROPHYVENTRICULAR ARRHYTHMIASCHRONIC RENAL FAILUREHEMODIALYSISLEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTSinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/251742023-01-12 22:03:33.999metadata only accessoai:repositorio.unifesp.br:11600/25174Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-01-13T01:03:33Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.en.fl_str_mv |
LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS |
title |
LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS |
spellingShingle |
LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS Saragoca, Manoel A. [UNIFESP] LEFT VENTRICULAR HYPERTROPHY CARDIAC HYPERTROPHY VENTRICULAR ARRHYTHMIAS CHRONIC RENAL FAILURE HEMODIALYSIS |
title_short |
LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS |
title_full |
LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS |
title_fullStr |
LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS |
title_full_unstemmed |
LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS |
title_sort |
LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS |
author |
Saragoca, Manoel A. [UNIFESP] |
author_facet |
Saragoca, Manoel A. [UNIFESP] Canziani, M. E. [UNIFESP] Cassiolato, José L. Gil, M. A. [UNIFESP] Andrade, J. L. [UNIFESP] Draibe, S. A. [UNIFESP] Martinez, E. E. [UNIFESP] |
author_role |
author |
author2 |
Canziani, M. E. [UNIFESP] Cassiolato, José L. Gil, M. A. [UNIFESP] Andrade, J. L. [UNIFESP] Draibe, S. A. [UNIFESP] Martinez, E. E. [UNIFESP] |
author2_role |
author author author author author author |
dc.contributor.institution.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) CENTROCOR |
dc.contributor.author.fl_str_mv |
Saragoca, Manoel A. [UNIFESP] Canziani, M. E. [UNIFESP] Cassiolato, José L. Gil, M. A. [UNIFESP] Andrade, J. L. [UNIFESP] Draibe, S. A. [UNIFESP] Martinez, E. E. [UNIFESP] |
dc.subject.eng.fl_str_mv |
LEFT VENTRICULAR HYPERTROPHY CARDIAC HYPERTROPHY VENTRICULAR ARRHYTHMIAS CHRONIC RENAL FAILURE HEMODIALYSIS |
topic |
LEFT VENTRICULAR HYPERTROPHY CARDIAC HYPERTROPHY VENTRICULAR ARRHYTHMIAS CHRONIC RENAL FAILURE HEMODIALYSIS |
description |
The contribution of left ventricular hypertrophy in determining ventricular arrhythmias (VAS) was studied in 81 chronic renal failure patients in chronic hemodialysis using two-dimensional echocardiographic and electrocardiogram Holter monitoring. the prevalence of LVH was 93% (96% in hypertensive and 87% in normotensive patients). the prevalence of VA was 48%. These arrhythmias were associated with increased cardiac mass, lack of potassium supplementation to the hemodialysis bath, and low K+ and PaO2 during dialysis. Severe forms of VA occurred in 19 of 78 patients, and the risk factors for this occurrence were (a) largely increased cardiac mass indices (exceeding in more than 40% the upper limit of normal for each sex) and (b) prolonged periods of time in hemodialysis treatment (34 +/- 5.5 vs. 17 +/- 2.7 months, p < 0.05). Changes in potassium or oxygen content of the blood were not significantly associated with the occurrence of severe forms of VA. |
publishDate |
1991 |
dc.date.issued.fl_str_mv |
1991-01-01 |
dc.date.accessioned.fl_str_mv |
2016-01-24T11:40:00Z |
dc.date.available.fl_str_mv |
2016-01-24T11:40:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
Journal of Cardiovascular Pharmacology. Philadelphia: Lippincott-raven Publ, v. 17, p. S136-S138, 1991. |
dc.identifier.uri.fl_str_mv |
http://repositorio.unifesp.br/handle/11600/25174 http://dx.doi.org/10.1097/00005344-199117002-00032 |
dc.identifier.issn.none.fl_str_mv |
0160-2446 |
dc.identifier.doi.none.fl_str_mv |
10.1097/00005344-199117002-00032 |
dc.identifier.wos.none.fl_str_mv |
WOS:A1991FU76000032 |
identifier_str_mv |
Journal of Cardiovascular Pharmacology. Philadelphia: Lippincott-raven Publ, v. 17, p. S136-S138, 1991. 0160-2446 10.1097/00005344-199117002-00032 WOS:A1991FU76000032 |
url |
http://repositorio.unifesp.br/handle/11600/25174 http://dx.doi.org/10.1097/00005344-199117002-00032 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.none.fl_str_mv |
Journal of Cardiovascular Pharmacology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
S136-S138 |
dc.publisher.none.fl_str_mv |
Lippincott-raven Publ |
publisher.none.fl_str_mv |
Lippincott-raven Publ |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
|
_version_ |
1802764122197065728 |